

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 6.05376538 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 5.85285195 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 4.91722653 |
| 4 | Golgi transport vesicle coating (GO:0048200) | 4.91722653 |
| 5 | protein maturation by protein folding (GO:0022417) | 4.59694057 |
| 6 | respiratory chain complex IV assembly (GO:0008535) | 4.58086985 |
| 7 | facial nerve structural organization (GO:0021612) | 4.55429527 |
| 8 | viral transcription (GO:0019083) | 4.40531068 |
| 9 | proteasome assembly (GO:0043248) | 4.23802368 |
| 10 | translational termination (GO:0006415) | 4.18670313 |
| 11 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.15005284 |
| 12 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.14215909 |
| 13 | gonadal mesoderm development (GO:0007506) | 4.10070749 |
| 14 | cotranslational protein targeting to membrane (GO:0006613) | 4.03203765 |
| 15 | protein targeting to ER (GO:0045047) | 4.00317471 |
| 16 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.99443978 |
| 17 | lymphoid progenitor cell differentiation (GO:0002320) | 3.98061889 |
| 18 | proline biosynthetic process (GO:0006561) | 3.94413048 |
| 19 | cytochrome complex assembly (GO:0017004) | 3.89062463 |
| 20 | protein localization to endoplasmic reticulum (GO:0070972) | 3.82072568 |
| 21 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.80738593 |
| 22 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.76808159 |
| 23 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.75472608 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.67855956 |
| 25 | platelet dense granule organization (GO:0060155) | 3.67853194 |
| 26 | ribosomal small subunit biogenesis (GO:0042274) | 3.65655887 |
| 27 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.64876948 |
| 28 | response to interferon-beta (GO:0035456) | 3.63854821 |
| 29 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.63037241 |
| 30 | immunoglobulin mediated immune response (GO:0016064) | 3.57272362 |
| 31 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.55469615 |
| 32 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.55469615 |
| 33 | maturation of SSU-rRNA (GO:0030490) | 3.55278367 |
| 34 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.51644318 |
| 35 | translational elongation (GO:0006414) | 3.50367827 |
| 36 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.49787921 |
| 37 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.49787921 |
| 38 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.49787921 |
| 39 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.47441018 |
| 40 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.47441018 |
| 41 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.47013176 |
| 42 | mannosylation (GO:0097502) | 3.44853389 |
| 43 | negative regulation of B cell apoptotic process (GO:0002903) | 3.42830702 |
| 44 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.42118903 |
| 45 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 3.36703050 |
| 46 | GDP-mannose metabolic process (GO:0019673) | 3.36346524 |
| 47 | negative regulation of ligase activity (GO:0051352) | 3.35892878 |
| 48 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.35892878 |
| 49 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.34474033 |
| 50 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.32902820 |
| 51 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.32276723 |
| 52 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.32276723 |
| 53 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.31267546 |
| 54 | amino sugar catabolic process (GO:0046348) | 3.30975924 |
| 55 | telomere maintenance via recombination (GO:0000722) | 3.30389560 |
| 56 | viral life cycle (GO:0019058) | 3.29704097 |
| 57 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.28568061 |
| 58 | GMP metabolic process (GO:0046037) | 3.25168402 |
| 59 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.25050405 |
| 60 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.22665217 |
| 61 | mature B cell differentiation involved in immune response (GO:0002313) | 3.20981092 |
| 62 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.20809708 |
| 63 | formation of translation preinitiation complex (GO:0001731) | 3.20502066 |
| 64 | protein targeting to mitochondrion (GO:0006626) | 3.19490824 |
| 65 | negative regulation of myotube differentiation (GO:0010832) | 3.09408753 |
| 66 | positive regulation of ligase activity (GO:0051351) | 3.08559050 |
| 67 | cullin deneddylation (GO:0010388) | 3.07662111 |
| 68 | cellular protein complex disassembly (GO:0043624) | 3.06071926 |
| 69 | postsynaptic membrane organization (GO:0001941) | 3.04787835 |
| 70 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.04511748 |
| 71 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.03210760 |
| 72 | endosome to pigment granule transport (GO:0043485) | 3.02428791 |
| 73 | endosome to melanosome transport (GO:0035646) | 3.02428791 |
| 74 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.02428568 |
| 75 | tRNA methylation (GO:0030488) | 3.01377424 |
| 76 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.99699820 |
| 77 | regulation of translational fidelity (GO:0006450) | 2.99434625 |
| 78 | mitochondrial fusion (GO:0008053) | 2.98294307 |
| 79 | N-acetylneuraminate metabolic process (GO:0006054) | 2.97577249 |
| 80 | cranial nerve structural organization (GO:0021604) | 2.97353115 |
| 81 | heme biosynthetic process (GO:0006783) | 2.96665751 |
| 82 | modulation by virus of host process (GO:0019054) | 2.95659058 |
| 83 | DNA strand elongation (GO:0022616) | 2.95437132 |
| 84 | DNA replication initiation (GO:0006270) | 2.94624295 |
| 85 | protein deneddylation (GO:0000338) | 2.93909554 |
| 86 | ribosome biogenesis (GO:0042254) | 2.93711982 |
| 87 | establishment of protein localization to mitochondrion (GO:0072655) | 2.93541624 |
| 88 | translational initiation (GO:0006413) | 2.92924378 |
| 89 | positive regulation of cell cycle arrest (GO:0071158) | 2.92592315 |
| 90 | termination of RNA polymerase III transcription (GO:0006386) | 2.92009393 |
| 91 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.92009393 |
| 92 | nuclear envelope reassembly (GO:0031468) | 2.91176043 |
| 93 | mitotic nuclear envelope reassembly (GO:0007084) | 2.91176043 |
| 94 | membrane invagination (GO:0010324) | 2.90928120 |
| 95 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.89859369 |
| 96 | C-terminal protein lipidation (GO:0006501) | 2.89823220 |
| 97 | cranial nerve morphogenesis (GO:0021602) | 2.87925364 |
| 98 | defense response to protozoan (GO:0042832) | 2.87576663 |
| 99 | metallo-sulfur cluster assembly (GO:0031163) | 2.86479128 |
| 100 | iron-sulfur cluster assembly (GO:0016226) | 2.86479128 |
| 101 | protein localization to mitochondrion (GO:0070585) | 2.86359760 |
| 102 | B cell mediated immunity (GO:0019724) | 2.86096103 |
| 103 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.85547091 |
| 104 | pseudouridine synthesis (GO:0001522) | 2.85344274 |
| 105 | mature B cell differentiation (GO:0002335) | 2.84774181 |
| 106 | rRNA modification (GO:0000154) | 2.84065188 |
| 107 | tRNA aminoacylation (GO:0043039) | 2.83439992 |
| 108 | amino acid activation (GO:0043038) | 2.83439992 |
| 109 | tRNA aminoacylation for protein translation (GO:0006418) | 2.83175905 |
| 110 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.82876877 |
| 111 | GPI anchor biosynthetic process (GO:0006506) | 2.82286588 |
| 112 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.78871389 |
| 113 | regulation of translation in response to stress (GO:0043555) | 2.78239033 |
| 114 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.77944015 |
| 115 | response to interferon-alpha (GO:0035455) | 2.77502164 |
| 116 | regulation of chromatin binding (GO:0035561) | 2.75420642 |
| 117 | regulation of ligase activity (GO:0051340) | 2.74230655 |
| 118 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.73729314 |
| 119 | cellular response to interferon-beta (GO:0035458) | 2.73431343 |
| 120 | ribosome assembly (GO:0042255) | 2.72428562 |
| 121 | phospholipid scrambling (GO:0017121) | 2.72048227 |
| 122 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.70310076 |
| 123 | ribosomal large subunit biogenesis (GO:0042273) | 2.70048122 |
| 124 | mitotic recombination (GO:0006312) | 2.69764503 |
| 125 | mast cell activation (GO:0045576) | 2.69548531 |
| 126 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.69345234 |
| 127 | telomere maintenance via telomere lengthening (GO:0010833) | 2.69031119 |
| 128 | negative regulation of protein ubiquitination (GO:0031397) | 2.67908248 |
| 129 | translation (GO:0006412) | 2.67747865 |
| 130 | protein complex disassembly (GO:0043241) | 2.66562156 |
| 131 | negative regulation of type 2 immune response (GO:0002829) | 2.66022327 |
| 132 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.64643979 |
| 133 | response to protozoan (GO:0001562) | 2.64074501 |
| 134 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.61836118 |
| 135 | mitotic metaphase plate congression (GO:0007080) | 2.61462818 |
| 136 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.60517378 |
| 137 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.60327234 |
| 138 | NIK/NF-kappaB signaling (GO:0038061) | 2.60091318 |
| 139 | regulation of cell cycle arrest (GO:0071156) | 2.59867612 |
| 140 | positive regulation of protein homooligomerization (GO:0032464) | 2.59808847 |
| 141 | response to peptidoglycan (GO:0032494) | 2.59301965 |
| 142 | regulation of pigment cell differentiation (GO:0050932) | 2.58399177 |
| 143 | tetrapyrrole biosynthetic process (GO:0033014) | 2.58095108 |
| 144 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.56599240 |
| 145 | definitive hemopoiesis (GO:0060216) | 2.56369163 |
| 146 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.55640954 |
| 147 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.54760444 |
| 148 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.54331486 |
| 149 | regulation of mitochondrial translation (GO:0070129) | 2.54287130 |
| 150 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.53833687 |
| 151 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.52856637 |
| 152 | macromolecular complex disassembly (GO:0032984) | 2.51389201 |
| 153 | detection of bacterium (GO:0016045) | 2.51185270 |
| 154 | viral protein processing (GO:0019082) | 2.50785903 |
| 155 | signal peptide processing (GO:0006465) | 2.50305090 |
| 156 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.49932029 |
| 157 | chaperone-mediated protein transport (GO:0072321) | 2.49752737 |
| 158 | pentose metabolic process (GO:0019321) | 2.49615507 |
| 159 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.49509863 |
| 160 | signal transduction in response to DNA damage (GO:0042770) | 2.49072297 |
| 161 | positive regulation of B cell differentiation (GO:0045579) | 2.48625713 |
| 162 | mitotic chromosome condensation (GO:0007076) | 2.47862606 |
| 163 | protein retention in ER lumen (GO:0006621) | 2.47841921 |
| 164 | proline metabolic process (GO:0006560) | 2.46916349 |
| 165 | peptidyl-histidine modification (GO:0018202) | 2.46595194 |
| 166 | L-fucose catabolic process (GO:0042355) | 2.45439533 |
| 167 | fucose catabolic process (GO:0019317) | 2.45439533 |
| 168 | L-fucose metabolic process (GO:0042354) | 2.45439533 |
| 169 | regulation of RIG-I signaling pathway (GO:0039535) | 2.45308426 |
| 170 | snRNA metabolic process (GO:0016073) | 2.45291827 |
| 171 | negative regulation of metanephros development (GO:0072217) | 2.44202508 |
| 172 | positive regulation of granulocyte differentiation (GO:0030854) | 2.43758211 |
| 173 | DNA damage response, detection of DNA damage (GO:0042769) | 2.43607312 |
| 174 | regulation of B cell apoptotic process (GO:0002902) | 2.43284193 |
| 175 | negative regulation of B cell mediated immunity (GO:0002713) | 2.43157714 |
| 176 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.43157714 |
| 177 | protein targeting to membrane (GO:0006612) | 2.42782796 |
| 178 | C-terminal protein amino acid modification (GO:0018410) | 2.42466536 |
| 179 | de novo posttranslational protein folding (GO:0051084) | 2.42162484 |
| 180 | de novo protein folding (GO:0006458) | 2.41310398 |
| 181 | viral mRNA export from host cell nucleus (GO:0046784) | 2.40778219 |
| 182 | regulation of cellular amine metabolic process (GO:0033238) | 2.40605972 |
| 183 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.40325143 |
| 184 | positive regulation of nuclease activity (GO:0032075) | 2.39303889 |
| 185 | spliceosomal snRNP assembly (GO:0000387) | 2.38631495 |
| 186 | protein insertion into membrane (GO:0051205) | 2.38479132 |
| 187 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.38018934 |
| 188 | heme metabolic process (GO:0042168) | 2.37848044 |
| 189 | virion assembly (GO:0019068) | 2.37701917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.86749388 |
| 2 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.49018061 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.26412816 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.13624364 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.04966913 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.04833658 |
| 7 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.99248005 |
| 8 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.93746049 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.90949746 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.90174720 |
| 11 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.89767273 |
| 12 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.89266082 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.80798174 |
| 14 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.78554394 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.72653729 |
| 16 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.72380672 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.69426297 |
| 18 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.60617214 |
| 19 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.50927730 |
| 20 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.43156321 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.41536853 |
| 22 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.37180030 |
| 23 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.34448307 |
| 24 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.32193172 |
| 25 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.29448469 |
| 26 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.26295880 |
| 27 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.25387385 |
| 28 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.19666338 |
| 29 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.17947113 |
| 30 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.17569243 |
| 31 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.14087296 |
| 32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.07645477 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.06301170 |
| 34 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04705633 |
| 35 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.04030361 |
| 36 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.99059555 |
| 37 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.95228741 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92687788 |
| 39 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.92553912 |
| 40 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.91394434 |
| 41 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.84905916 |
| 42 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.82859364 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.82054744 |
| 44 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.80210074 |
| 45 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.76615097 |
| 46 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76086998 |
| 47 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.76012971 |
| 48 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.73951992 |
| 49 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.72255486 |
| 50 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.68530367 |
| 51 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.66191020 |
| 52 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.65478172 |
| 53 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.62733370 |
| 54 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.61905949 |
| 55 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.61477892 |
| 56 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.60992624 |
| 57 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.56740482 |
| 58 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.53067218 |
| 59 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.53020610 |
| 60 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.51070401 |
| 61 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.50448165 |
| 62 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.44825439 |
| 63 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.42864558 |
| 64 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.42846266 |
| 65 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.42042862 |
| 66 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.41859321 |
| 67 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41763056 |
| 68 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41189461 |
| 69 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.39961954 |
| 70 | * MAF_26560356_Chip-Seq_TH2_Human | 1.36686018 |
| 71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.35355583 |
| 72 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.32923194 |
| 73 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.32407684 |
| 74 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32284630 |
| 75 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.31545666 |
| 76 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.31355459 |
| 77 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.30406744 |
| 78 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.30068366 |
| 79 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.29811990 |
| 80 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.29335287 |
| 81 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.27304129 |
| 82 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.27156723 |
| 83 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.25365694 |
| 84 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22692843 |
| 85 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.22301050 |
| 86 | UTX_26944678_Chip-Seq_JUKART_Human | 1.21769607 |
| 87 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.20424126 |
| 88 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.19464313 |
| 89 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.18318241 |
| 90 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.18004430 |
| 91 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.16848192 |
| 92 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16471564 |
| 93 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.16071816 |
| 94 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14984427 |
| 95 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.14441292 |
| 96 | * MYB_26560356_Chip-Seq_TH2_Human | 1.14210275 |
| 97 | MYC_22102868_ChIP-Seq_BL_Human | 1.12730143 |
| 98 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.12643636 |
| 99 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.10936483 |
| 100 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.10757096 |
| 101 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.10526615 |
| 102 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07925686 |
| 103 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07619473 |
| 104 | MAF_26560356_Chip-Seq_TH1_Human | 1.07300429 |
| 105 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.07297582 |
| 106 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07275266 |
| 107 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05809295 |
| 108 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05388135 |
| 109 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04489937 |
| 110 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.04085881 |
| 111 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.03639986 |
| 112 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.02848489 |
| 113 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.01934216 |
| 114 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01664745 |
| 115 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01206853 |
| 116 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.01167472 |
| 117 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.01099603 |
| 118 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.00928933 |
| 119 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00868183 |
| 120 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00753403 |
| 121 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99890278 |
| 122 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98718557 |
| 123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97917426 |
| 124 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97775911 |
| 125 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.97203043 |
| 126 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.96950111 |
| 127 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.96764694 |
| 128 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.96700610 |
| 129 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96470033 |
| 130 | MYB_26560356_Chip-Seq_TH1_Human | 0.95111337 |
| 131 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.95005157 |
| 132 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.94194359 |
| 133 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.91736257 |
| 134 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.89597732 |
| 135 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.89021102 |
| 136 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.87951421 |
| 137 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87140913 |
| 138 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86849126 |
| 139 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.86532217 |
| 140 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.86285916 |
| 141 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.84892553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 3.82091014 |
| 2 | MP0005174_abnormal_tail_pigmentation | 3.57179797 |
| 3 | MP0005409_darkened_coat_color | 3.42451057 |
| 4 | MP0001188_hyperpigmentation | 3.35510253 |
| 5 | MP0006292_abnormal_olfactory_placode | 3.32628472 |
| 6 | MP0000015_abnormal_ear_pigmentation | 3.16240154 |
| 7 | MP0003111_abnormal_nucleus_morphology | 3.03832984 |
| 8 | MP0003136_yellow_coat_color | 2.87490871 |
| 9 | MP0001986_abnormal_taste_sensitivity | 2.82770346 |
| 10 | MP0005451_abnormal_body_composition | 2.81591333 |
| 11 | MP0005075_abnormal_melanosome_morpholog | 2.79663685 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.65816673 |
| 13 | MP0009785_altered_susceptibility_to | 2.61573052 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.60172989 |
| 15 | MP0003724_increased_susceptibility_to | 2.56485940 |
| 16 | MP0008260_abnormal_autophagy | 2.51857383 |
| 17 | MP0005671_abnormal_response_to | 2.50947788 |
| 18 | MP0004957_abnormal_blastocyst_morpholog | 2.41896241 |
| 19 | MP0000685_abnormal_immune_system | 2.30048247 |
| 20 | MP0005083_abnormal_biliary_tract | 2.19720070 |
| 21 | MP0002396_abnormal_hematopoietic_system | 2.18817661 |
| 22 | MP0002095_abnormal_skin_pigmentation | 2.17186444 |
| 23 | MP0000372_irregular_coat_pigmentation | 2.16398184 |
| 24 | MP0002876_abnormal_thyroid_physiology | 2.12803442 |
| 25 | MP0003763_abnormal_thymus_physiology | 2.07096148 |
| 26 | MP0005025_abnormal_response_to | 2.03778640 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 2.03005866 |
| 28 | MP0004381_abnormal_hair_follicle | 1.98245430 |
| 29 | MP0000681_abnormal_thyroid_gland | 1.96186125 |
| 30 | MP0001853_heart_inflammation | 1.93083415 |
| 31 | MP0000490_abnormal_crypts_of | 1.86132970 |
| 32 | MP0001730_embryonic_growth_arrest | 1.84188820 |
| 33 | MP0009840_abnormal_foam_cell | 1.83053329 |
| 34 | MP0006035_abnormal_mitochondrial_morpho | 1.82013581 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.78619303 |
| 36 | MP0003436_decreased_susceptibility_to | 1.78592654 |
| 37 | MP0003806_abnormal_nucleotide_metabolis | 1.78037447 |
| 38 | MP0003693_abnormal_embryo_hatching | 1.76188799 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.76149754 |
| 40 | MP0005000_abnormal_immune_tolerance | 1.75781717 |
| 41 | MP0001661_extended_life_span | 1.66393705 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.65705849 |
| 43 | MP0008058_abnormal_DNA_repair | 1.64119629 |
| 44 | MP0001819_abnormal_immune_cell | 1.63767964 |
| 45 | MP0002723_abnormal_immune_serum | 1.63321762 |
| 46 | MP0001800_abnormal_humoral_immune | 1.61066942 |
| 47 | MP0002419_abnormal_innate_immunity | 1.60245690 |
| 48 | MP0008932_abnormal_embryonic_tissue | 1.59748240 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.55972754 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.55972754 |
| 51 | MP0000313_abnormal_cell_death | 1.55763729 |
| 52 | MP0002452_abnormal_antigen_presenting | 1.55313629 |
| 53 | MP0002398_abnormal_bone_marrow | 1.55261091 |
| 54 | MP0002132_abnormal_respiratory_system | 1.48198265 |
| 55 | MP0005501_abnormal_skin_physiology | 1.46801949 |
| 56 | MP0003186_abnormal_redox_activity | 1.46634301 |
| 57 | MP0006036_abnormal_mitochondrial_physio | 1.46538217 |
| 58 | MP0000358_abnormal_cell_content/ | 1.44661136 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.43987177 |
| 60 | MP0003866_abnormal_defecation | 1.40915162 |
| 61 | MP0004264_abnormal_extraembryonic_tissu | 1.40495512 |
| 62 | MP0000678_abnormal_parathyroid_gland | 1.36387763 |
| 63 | MP0000716_abnormal_immune_system | 1.35215605 |
| 64 | MP0002822_catalepsy | 1.34369701 |
| 65 | MP0000689_abnormal_spleen_morphology | 1.33553577 |
| 66 | MP0004808_abnormal_hematopoietic_stem | 1.33428669 |
| 67 | MP0000350_abnormal_cell_proliferation | 1.31387857 |
| 68 | MP0005387_immune_system_phenotype | 1.30462792 |
| 69 | MP0001790_abnormal_immune_system | 1.30462792 |
| 70 | MP0003943_abnormal_hepatobiliary_system | 1.26614849 |
| 71 | MP0002080_prenatal_lethality | 1.26324965 |
| 72 | MP0008007_abnormal_cellular_replicative | 1.24880982 |
| 73 | MP0001727_abnormal_embryo_implantation | 1.23724501 |
| 74 | MP0005408_hypopigmentation | 1.22129989 |
| 75 | MP0002722_abnormal_immune_system | 1.21874336 |
| 76 | MP0002751_abnormal_autonomic_nervous | 1.20480908 |
| 77 | MP0002429_abnormal_blood_cell | 1.19695195 |
| 78 | MP0003786_premature_aging | 1.18493487 |
| 79 | MP0003172_abnormal_lysosome_physiology | 1.18193365 |
| 80 | MP0003221_abnormal_cardiomyocyte_apopto | 1.16977355 |
| 81 | MP0010155_abnormal_intestine_physiology | 1.13649940 |
| 82 | MP0002638_abnormal_pupillary_reflex | 1.12379007 |
| 83 | MP0002166_altered_tumor_susceptibility | 1.12094221 |
| 84 | MP0004147_increased_porphyrin_level | 1.10523432 |
| 85 | MP0001873_stomach_inflammation | 1.09198007 |
| 86 | MP0003880_abnormal_central_pattern | 1.08177865 |
| 87 | MP0002405_respiratory_system_inflammati | 1.08108316 |
| 88 | MP0001697_abnormal_embryo_size | 1.07534414 |
| 89 | MP0002177_abnormal_outer_ear | 1.07439629 |
| 90 | MP0005310_abnormal_salivary_gland | 1.04651588 |
| 91 | MP0003879_abnormal_hair_cell | 1.03342031 |
| 92 | MP0008995_early_reproductive_senescence | 1.03120494 |
| 93 | MP0002877_abnormal_melanocyte_morpholog | 1.02892452 |
| 94 | MP0001672_abnormal_embryogenesis/_devel | 1.02692456 |
| 95 | MP0005380_embryogenesis_phenotype | 1.02692456 |
| 96 | MP0003646_muscle_fatigue | 1.02605532 |
| 97 | MP0003303_peritoneal_inflammation | 1.01278689 |
| 98 | MP0005379_endocrine/exocrine_gland_phen | 0.97725367 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 0.97639644 |
| 100 | MP0001845_abnormal_inflammatory_respons | 0.97601299 |
| 101 | MP0005220_abnormal_exocrine_pancreas | 0.96878255 |
| 102 | MP0009931_abnormal_skin_appearance | 0.91050959 |
| 103 | MP0002086_abnormal_extraembryonic_tissu | 0.90516916 |
| 104 | MP0003984_embryonic_growth_retardation | 0.90444513 |
| 105 | MP0008469_abnormal_protein_level | 0.90206549 |
| 106 | MP0002938_white_spotting | 0.89611591 |
| 107 | MP0002006_tumorigenesis | 0.89536317 |
| 108 | MP0005384_cellular_phenotype | 0.89271647 |
| 109 | MP0000049_abnormal_middle_ear | 0.89055969 |
| 110 | MP0002088_abnormal_embryonic_growth/wei | 0.87757458 |
| 111 | MP0000703_abnormal_thymus_morphology | 0.86471612 |
| 112 | MP0001764_abnormal_homeostasis | 0.85399624 |
| 113 | MP0000631_abnormal_neuroendocrine_gland | 0.84926719 |
| 114 | MP0003183_abnormal_peptide_metabolism | 0.84712796 |
| 115 | MP0000598_abnormal_liver_morphology | 0.84338973 |
| 116 | MP0003315_abnormal_perineum_morphology | 0.84088358 |
| 117 | MP0002009_preneoplasia | 0.82669096 |
| 118 | MP0002653_abnormal_ependyma_morphology | 0.82470834 |
| 119 | MP0002277_abnormal_respiratory_mucosa | 0.82454884 |
| 120 | MP0001919_abnormal_reproductive_system | 0.82414538 |
| 121 | MP0010094_abnormal_chromosome_stability | 0.82226687 |
| 122 | MP0002075_abnormal_coat/hair_pigmentati | 0.81239594 |
| 123 | MP0002693_abnormal_pancreas_physiology | 0.80549990 |
| 124 | MP0005621_abnormal_cell_physiology | 0.79874730 |
| 125 | MP0005171_absent_coat_pigmentation | 0.79656180 |
| 126 | MP0009278_abnormal_bone_marrow | 0.79371762 |
| 127 | MP0002796_impaired_skin_barrier | 0.78122228 |
| 128 | MP0004233_abnormal_muscle_weight | 0.77238079 |
| 129 | MP0001663_abnormal_digestive_system | 0.75618585 |
| 130 | MP0002210_abnormal_sex_determination | 0.75017223 |
| 131 | MP0001533_abnormal_skeleton_physiology | 0.73651609 |
| 132 | MP0001186_pigmentation_phenotype | 0.71195371 |
| 133 | MP0002163_abnormal_gland_morphology | 0.70966207 |
| 134 | MP0002102_abnormal_ear_morphology | 0.70372488 |
| 135 | MP0003718_maternal_effect | 0.69645149 |
| 136 | MP0000613_abnormal_salivary_gland | 0.69467484 |
| 137 | MP0002160_abnormal_reproductive_system | 0.69459267 |
| 138 | MP0005646_abnormal_pituitary_gland | 0.68543796 |
| 139 | MP0000858_altered_metastatic_potential | 0.66397236 |
| 140 | MP0000371_diluted_coat_color | 0.65295933 |
| 141 | MP0002019_abnormal_tumor_incidence | 0.64542891 |
| 142 | MP0003656_abnormal_erythrocyte_physiolo | 0.60923642 |
| 143 | MP0009764_decreased_sensitivity_to | 0.58432777 |
| 144 | MP0004782_abnormal_surfactant_physiolog | 0.57259677 |
| 145 | MP0001348_abnormal_lacrimal_gland | 0.57213317 |
| 146 | MP0003938_abnormal_ear_development | 0.56379111 |
| 147 | MP0003077_abnormal_cell_cycle | 0.56199846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type I transferrin isoform profile (HP:0003642) | 6.74241566 |
| 2 | Reduced antithrombin III activity (HP:0001976) | 6.14043170 |
| 3 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 4.83516209 |
| 4 | Abnormal protein N-linked glycosylation (HP:0012347) | 4.83516209 |
| 5 | Abnormal protein glycosylation (HP:0012346) | 4.83516209 |
| 6 | Abnormal glycosylation (HP:0012345) | 4.83516209 |
| 7 | Aplastic anemia (HP:0001915) | 4.30137443 |
| 8 | Cholecystitis (HP:0001082) | 4.30104939 |
| 9 | Abnormal gallbladder physiology (HP:0012438) | 4.30104939 |
| 10 | Abnormal number of erythroid precursors (HP:0012131) | 4.24517237 |
| 11 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.21322917 |
| 12 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.81035424 |
| 13 | Nonprogressive disorder (HP:0003680) | 3.68381782 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.61733245 |
| 15 | Severe visual impairment (HP:0001141) | 3.42707823 |
| 16 | Hypothermia (HP:0002045) | 3.39397930 |
| 17 | Thyroid-stimulating hormone excess (HP:0002925) | 3.34443169 |
| 18 | Type 2 muscle fiber atrophy (HP:0003554) | 3.33611427 |
| 19 | Reticulocytopenia (HP:0001896) | 3.31335696 |
| 20 | Cerebral hypomyelination (HP:0006808) | 3.19271601 |
| 21 | Thrombocytosis (HP:0001894) | 3.13258378 |
| 22 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.04995182 |
| 23 | Rough bone trabeculation (HP:0100670) | 3.03425546 |
| 24 | Muscle fiber atrophy (HP:0100295) | 3.02703506 |
| 25 | Cholelithiasis (HP:0001081) | 2.97859894 |
| 26 | Dry hair (HP:0011359) | 2.96761863 |
| 27 | Increased hepatocellular lipid droplets (HP:0006565) | 2.90486018 |
| 28 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.89463058 |
| 29 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.89434661 |
| 30 | Renal Fanconi syndrome (HP:0001994) | 2.83917118 |
| 31 | Abnormality of the columella (HP:0009929) | 2.80584484 |
| 32 | Myositis (HP:0100614) | 2.79198469 |
| 33 | Hypertensive crisis (HP:0100735) | 2.76040826 |
| 34 | Recurrent abscess formation (HP:0002722) | 2.72481962 |
| 35 | Reticulocytosis (HP:0001923) | 2.69913957 |
| 36 | Exertional dyspnea (HP:0002875) | 2.69708114 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 2.63831156 |
| 38 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.63490324 |
| 39 | Petechiae (HP:0000967) | 2.62542200 |
| 40 | True hermaphroditism (HP:0010459) | 2.62063270 |
| 41 | Hepatocellular necrosis (HP:0001404) | 2.61037996 |
| 42 | Abnormal gallbladder morphology (HP:0012437) | 2.58696537 |
| 43 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.56230278 |
| 44 | IgM deficiency (HP:0002850) | 2.55792729 |
| 45 | Acute necrotizing encephalopathy (HP:0006965) | 2.54901840 |
| 46 | Meningitis (HP:0001287) | 2.53794844 |
| 47 | Pustule (HP:0200039) | 2.53378057 |
| 48 | Testicular atrophy (HP:0000029) | 2.52246572 |
| 49 | 3-Methylglutaconic aciduria (HP:0003535) | 2.51600612 |
| 50 | Upper limb muscle weakness (HP:0003484) | 2.42000090 |
| 51 | Abnormality of magnesium homeostasis (HP:0004921) | 2.40309909 |
| 52 | Trismus (HP:0000211) | 2.38185958 |
| 53 | Acute encephalopathy (HP:0006846) | 2.37886268 |
| 54 | Lipid accumulation in hepatocytes (HP:0006561) | 2.37546592 |
| 55 | Attenuation of retinal blood vessels (HP:0007843) | 2.36814194 |
| 56 | Chronic obstructive pulmonary disease (HP:0006510) | 2.36670295 |
| 57 | Obstructive lung disease (HP:0006536) | 2.36670295 |
| 58 | Pallor (HP:0000980) | 2.35942997 |
| 59 | Nonimmune hydrops fetalis (HP:0001790) | 2.35218463 |
| 60 | Thoracic kyphosis (HP:0002942) | 2.32027187 |
| 61 | Seborrheic dermatitis (HP:0001051) | 2.31937145 |
| 62 | Abnormal trabecular bone morphology (HP:0100671) | 2.31310488 |
| 63 | Broad face (HP:0000283) | 2.30734644 |
| 64 | Prolonged bleeding time (HP:0003010) | 2.26855821 |
| 65 | Abnormality of lateral ventricle (HP:0030047) | 2.25621946 |
| 66 | Macrocytic anemia (HP:0001972) | 2.25248034 |
| 67 | Cortical visual impairment (HP:0100704) | 2.24897761 |
| 68 | Microvesicular hepatic steatosis (HP:0001414) | 2.24411818 |
| 69 | Chronic otitis media (HP:0000389) | 2.23029650 |
| 70 | Ragged-red muscle fibers (HP:0003200) | 2.22355188 |
| 71 | Abnormality of the gallbladder (HP:0005264) | 2.21228840 |
| 72 | Abnormality of reticulocytes (HP:0004312) | 2.19892318 |
| 73 | Abnormality of the prostate (HP:0008775) | 2.18790957 |
| 74 | Microcytic anemia (HP:0001935) | 2.17805214 |
| 75 | Recurrent viral infections (HP:0004429) | 2.17351997 |
| 76 | Cutaneous melanoma (HP:0012056) | 2.16679954 |
| 77 | Premature ovarian failure (HP:0008209) | 2.15974767 |
| 78 | Vertebral compression fractures (HP:0002953) | 2.15456904 |
| 79 | Abnormality of T cell physiology (HP:0011840) | 2.15290152 |
| 80 | Recurrent bacterial skin infections (HP:0005406) | 2.15269200 |
| 81 | Opisthotonus (HP:0002179) | 2.14986982 |
| 82 | Increased serum lactate (HP:0002151) | 2.14846052 |
| 83 | Villous atrophy (HP:0011473) | 2.14771288 |
| 84 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.14771288 |
| 85 | Increased CSF lactate (HP:0002490) | 2.14586699 |
| 86 | Hepatic necrosis (HP:0002605) | 2.14328664 |
| 87 | Pancytopenia (HP:0001876) | 2.13560371 |
| 88 | Increased intramyocellular lipid droplets (HP:0012240) | 2.13151897 |
| 89 | Diaphragmatic weakness (HP:0009113) | 2.12943561 |
| 90 | Progressive external ophthalmoplegia (HP:0000590) | 2.12636528 |
| 91 | Spastic paraparesis (HP:0002313) | 2.12542517 |
| 92 | Esophageal neoplasm (HP:0100751) | 2.12009512 |
| 93 | Neoplasm of head and neck (HP:0012288) | 2.12009512 |
| 94 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.09874330 |
| 95 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.09874330 |
| 96 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.08438646 |
| 97 | Hypochromic microcytic anemia (HP:0004840) | 2.08252904 |
| 98 | Progressive muscle weakness (HP:0003323) | 2.07823991 |
| 99 | Secondary amenorrhea (HP:0000869) | 2.07418134 |
| 100 | Death in infancy (HP:0001522) | 2.03816521 |
| 101 | Hypokinesia (HP:0002375) | 2.02630541 |
| 102 | Exercise intolerance (HP:0003546) | 2.01871896 |
| 103 | Stomatitis (HP:0010280) | 2.01679091 |
| 104 | Abnormality of the axillary hair (HP:0100134) | 2.00811151 |
| 105 | Abnormality of secondary sexual hair (HP:0009888) | 2.00811151 |
| 106 | Dicarboxylic aciduria (HP:0003215) | 2.00201285 |
| 107 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.00201285 |
| 108 | Pancreatic fibrosis (HP:0100732) | 1.99927226 |
| 109 | Respiratory difficulties (HP:0002880) | 1.99529012 |
| 110 | Abnormality of the anterior horn cell (HP:0006802) | 1.99313250 |
| 111 | Degeneration of anterior horn cells (HP:0002398) | 1.99313250 |
| 112 | Verrucae (HP:0200043) | 1.99058940 |
| 113 | Papilloma (HP:0012740) | 1.99058940 |
| 114 | Vacuolated lymphocytes (HP:0001922) | 1.97354641 |
| 115 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.96889613 |
| 116 | Abnormality of macrophages (HP:0004311) | 1.96642725 |
| 117 | Epistaxis (HP:0000421) | 1.95819830 |
| 118 | Progressive macrocephaly (HP:0004481) | 1.94868622 |
| 119 | Abnormality of DNA repair (HP:0003254) | 1.93744810 |
| 120 | CNS hypomyelination (HP:0003429) | 1.93735159 |
| 121 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.93454853 |
| 122 | Amaurosis fugax (HP:0100576) | 1.93081722 |
| 123 | Gastrointestinal inflammation (HP:0004386) | 1.92863180 |
| 124 | Loss of speech (HP:0002371) | 1.92642675 |
| 125 | Hypochromic anemia (HP:0001931) | 1.91547666 |
| 126 | Mitochondrial inheritance (HP:0001427) | 1.89469734 |
| 127 | Albinism (HP:0001022) | 1.89256819 |
| 128 | Pancreatic cysts (HP:0001737) | 1.88942050 |
| 129 | Gastrointestinal infarctions (HP:0005244) | 1.88444348 |
| 130 | Emotional lability (HP:0000712) | 1.88079037 |
| 131 | Abnormality of the preputium (HP:0100587) | 1.87697582 |
| 132 | Agammaglobulinemia (HP:0004432) | 1.86422814 |
| 133 | Hypoplasia of the fovea (HP:0007750) | 1.86282403 |
| 134 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.86282403 |
| 135 | Hepatosplenomegaly (HP:0001433) | 1.85620594 |
| 136 | Clubbing of toes (HP:0100760) | 1.85544108 |
| 137 | Capillary hemangiomas (HP:0005306) | 1.83700062 |
| 138 | Abnormality of renal resorption (HP:0011038) | 1.83567370 |
| 139 | Lactic acidosis (HP:0003128) | 1.82277204 |
| 140 | Panhypogammaglobulinemia (HP:0003139) | 1.82009833 |
| 141 | Delusions (HP:0000746) | 1.81999641 |
| 142 | Fatigue (HP:0012378) | 1.79270337 |
| 143 | Increased IgM level (HP:0003496) | 1.79048186 |
| 144 | Sparse eyelashes (HP:0000653) | 1.77699259 |
| 145 | Rhabdomyolysis (HP:0003201) | 1.76647239 |
| 146 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.75688338 |
| 147 | Recurrent cutaneous fungal infections (HP:0011370) | 1.75688338 |
| 148 | Pulmonary fibrosis (HP:0002206) | 1.75437416 |
| 149 | Chromsome breakage (HP:0040012) | 1.73899786 |
| 150 | Squamous cell carcinoma (HP:0002860) | 1.72705999 |
| 151 | Abnormality of glycolysis (HP:0004366) | 1.72274214 |
| 152 | Sex reversal (HP:0012245) | 1.72172609 |
| 153 | Abnormal sex determination (HP:0012244) | 1.72172609 |
| 154 | Renal tubular dysfunction (HP:0000124) | 1.71703941 |
| 155 | Abnormality of T cells (HP:0002843) | 1.71393608 |
| 156 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.70995006 |
| 157 | Entropion (HP:0000621) | 1.70710465 |
| 158 | Pendular nystagmus (HP:0012043) | 1.70692574 |
| 159 | Neutropenia (HP:0001875) | 1.70568431 |
| 160 | Poikiloderma (HP:0001029) | 1.70452293 |
| 161 | Hyperbilirubinemia (HP:0002904) | 1.69994770 |
| 162 | Recurrent bronchitis (HP:0002837) | 1.69532246 |
| 163 | Myelodysplasia (HP:0002863) | 1.68893729 |
| 164 | IgG deficiency (HP:0004315) | 1.68708384 |
| 165 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.68208731 |
| 166 | Acute lymphatic leukemia (HP:0006721) | 1.67277622 |
| 167 | Basal ganglia calcification (HP:0002135) | 1.66770750 |
| 168 | Ocular albinism (HP:0001107) | 1.63657427 |
| 169 | Increased muscle lipid content (HP:0009058) | 1.63571112 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 5.48072680 |
| 2 | MUSK | 4.82397783 |
| 3 | NME2 | 3.66257910 |
| 4 | EIF2AK3 | 3.46376560 |
| 5 | ERN1 | 3.39558716 |
| 6 | STK16 | 3.29241596 |
| 7 | VRK2 | 2.93071674 |
| 8 | EIF2AK1 | 2.81934309 |
| 9 | MKNK2 | 2.78976674 |
| 10 | SMG1 | 2.76621941 |
| 11 | NLK | 2.63728473 |
| 12 | TESK2 | 2.54909845 |
| 13 | TEC | 2.42620161 |
| 14 | IRAK4 | 2.30448060 |
| 15 | CAMKK2 | 2.20100026 |
| 16 | KIT | 2.11512832 |
| 17 | IRAK3 | 2.02697196 |
| 18 | MAP3K10 | 2.00930206 |
| 19 | CASK | 2.00746400 |
| 20 | WEE1 | 1.90587173 |
| 21 | MKNK1 | 1.88244048 |
| 22 | PIM2 | 1.77310137 |
| 23 | BCKDK | 1.73932724 |
| 24 | BTK | 1.64768202 |
| 25 | TRIB3 | 1.58851968 |
| 26 | CDK19 | 1.58609716 |
| 27 | MAP3K12 | 1.57804747 |
| 28 | VRK1 | 1.49856572 |
| 29 | TAOK1 | 1.44244424 |
| 30 | EIF2AK2 | 1.36952293 |
| 31 | ARAF | 1.36026032 |
| 32 | SIK1 | 1.34729027 |
| 33 | FLT3 | 1.34160380 |
| 34 | MAP2K7 | 1.33754974 |
| 35 | FES | 1.32072388 |
| 36 | TLK1 | 1.30275709 |
| 37 | GRK6 | 1.28087585 |
| 38 | LRRK2 | 1.26566081 |
| 39 | MAPKAPK3 | 1.26563404 |
| 40 | MAP3K3 | 1.26207520 |
| 41 | CAMK1 | 1.25691634 |
| 42 | MAP4K1 | 1.25601168 |
| 43 | PAK4 | 1.25416949 |
| 44 | NME1 | 1.24925537 |
| 45 | MARK3 | 1.22184899 |
| 46 | KSR2 | 1.20651620 |
| 47 | TXK | 1.19908532 |
| 48 | EPHA2 | 1.19157086 |
| 49 | TESK1 | 1.19141768 |
| 50 | PKN2 | 1.18894886 |
| 51 | IKBKB | 1.18702636 |
| 52 | ADRBK2 | 1.16162501 |
| 53 | DYRK3 | 1.15795576 |
| 54 | SRPK1 | 1.14805414 |
| 55 | SIK2 | 1.10050692 |
| 56 | TSSK6 | 1.09201995 |
| 57 | MAPK13 | 1.06654823 |
| 58 | BLK | 1.02967031 |
| 59 | TBK1 | 0.99424464 |
| 60 | YES1 | 0.99199005 |
| 61 | MAP3K8 | 0.98189893 |
| 62 | SCYL2 | 0.96707990 |
| 63 | SYK | 0.95899601 |
| 64 | IKBKE | 0.95484651 |
| 65 | BRSK2 | 0.93863971 |
| 66 | ACVR1B | 0.92231951 |
| 67 | RAF1 | 0.91532651 |
| 68 | MAP2K3 | 0.91442906 |
| 69 | PASK | 0.90273505 |
| 70 | MAP3K14 | 0.89858975 |
| 71 | STK4 | 0.89663332 |
| 72 | STK10 | 0.89488766 |
| 73 | TIE1 | 0.89405205 |
| 74 | ZAP70 | 0.87716052 |
| 75 | CLK1 | 0.86522596 |
| 76 | CDK9 | 0.85794816 |
| 77 | EEF2K | 0.83638024 |
| 78 | PRKG2 | 0.81671028 |
| 79 | TRIM28 | 0.80738486 |
| 80 | BUB1 | 0.80278965 |
| 81 | CSF1R | 0.79099646 |
| 82 | KDR | 0.77815439 |
| 83 | MATK | 0.77570232 |
| 84 | AURKA | 0.77400035 |
| 85 | TGFBR2 | 0.76946695 |
| 86 | RIPK4 | 0.75745489 |
| 87 | PBK | 0.75301684 |
| 88 | LYN | 0.75178349 |
| 89 | PRKCI | 0.74771345 |
| 90 | CCNB1 | 0.73164812 |
| 91 | BMX | 0.72705182 |
| 92 | MAP3K11 | 0.68607016 |
| 93 | MAPK15 | 0.68151640 |
| 94 | TAOK2 | 0.67745624 |
| 95 | HIPK2 | 0.66154018 |
| 96 | JAK3 | 0.65557129 |
| 97 | PDK2 | 0.65077156 |
| 98 | IRAK1 | 0.64978422 |
| 99 | CDK7 | 0.62395275 |
| 100 | TGFBR1 | 0.61339014 |
| 101 | MAP2K6 | 0.59272339 |
| 102 | CDK8 | 0.58719771 |
| 103 | MAPKAPK5 | 0.58016874 |
| 104 | ILK | 0.57793392 |
| 105 | PAK1 | 0.54502088 |
| 106 | CAMK4 | 0.54452387 |
| 107 | MAPK4 | 0.53645237 |
| 108 | RPS6KB2 | 0.53442633 |
| 109 | PIM1 | 0.52885796 |
| 110 | EPHB1 | 0.52737061 |
| 111 | PRKD2 | 0.52158768 |
| 112 | PLK4 | 0.51794418 |
| 113 | CDK3 | 0.51372502 |
| 114 | CAMKK1 | 0.50309764 |
| 115 | STK24 | 0.50089778 |
| 116 | GRK1 | 0.48843250 |
| 117 | CSNK1G1 | 0.48781838 |
| 118 | ATR | 0.48197965 |
| 119 | MAPK11 | 0.47906016 |
| 120 | LCK | 0.47014678 |
| 121 | MST1R | 0.45749765 |
| 122 | SIK3 | 0.45592254 |
| 123 | IRAK2 | 0.45559948 |
| 124 | NEK1 | 0.44326061 |
| 125 | TTK | 0.44108657 |
| 126 | RPS6KA4 | 0.43317389 |
| 127 | CHEK1 | 0.43263589 |
| 128 | BMPR1B | 0.42973208 |
| 129 | PLK3 | 0.42465550 |
| 130 | ICK | 0.41147086 |
| 131 | CDK12 | 0.40675659 |
| 132 | AURKB | 0.40097496 |
| 133 | BRAF | 0.39782020 |
| 134 | TYK2 | 0.39751842 |
| 135 | LMTK2 | 0.39731404 |
| 136 | MAPKAPK2 | 0.39517597 |
| 137 | PLK1 | 0.39047835 |
| 138 | MYLK | 0.38795567 |
| 139 | ZAK | 0.38348772 |
| 140 | GRK7 | 0.36271520 |
| 141 | MAP3K1 | 0.36198526 |
| 142 | BMPR2 | 0.35500784 |
| 143 | EPHA3 | 0.34519273 |
| 144 | DYRK2 | 0.34338706 |
| 145 | TAOK3 | 0.34301630 |
| 146 | PIK3CG | 0.33071053 |
| 147 | CSNK2A1 | 0.31776432 |
| 148 | CDK4 | 0.31138016 |
| 149 | TNK2 | 0.30935731 |
| 150 | CSNK1G3 | 0.29771723 |
| 151 | MST4 | 0.29050278 |
| 152 | MAPK12 | 0.28782796 |
| 153 | DAPK1 | 0.28473916 |
| 154 | PRPF4B | 0.27287284 |
| 155 | RPS6KA5 | 0.27027146 |
| 156 | BRSK1 | 0.26965461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.35622847 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.79383252 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.89661405 |
| 4 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.87706273 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.53532888 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.52303685 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.52210236 |
| 8 | Mismatch repair_Homo sapiens_hsa03430 | 2.41724588 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 2.39951390 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.22764493 |
| 11 | Proteasome_Homo sapiens_hsa03050 | 1.98328964 |
| 12 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.94972880 |
| 13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.87059532 |
| 14 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.78378239 |
| 15 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.78019175 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.77341518 |
| 17 | Spliceosome_Homo sapiens_hsa03040 | 1.77255091 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.73948887 |
| 19 | Purine metabolism_Homo sapiens_hsa00230 | 1.59404961 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.54319051 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.54106309 |
| 22 | Basal transcription factors_Homo sapiens_hsa03022 | 1.53075440 |
| 23 | * N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.49088041 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.48529582 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.39681163 |
| 26 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.38458577 |
| 27 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.37384777 |
| 28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.36940533 |
| 29 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.33923551 |
| 30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33193082 |
| 31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.31127630 |
| 32 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.28326921 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.28245350 |
| 34 | Allograft rejection_Homo sapiens_hsa05330 | 1.27298128 |
| 35 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.27184896 |
| 36 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.26318304 |
| 37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.25441178 |
| 38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.24423221 |
| 39 | Measles_Homo sapiens_hsa05162 | 1.22524036 |
| 40 | Leishmaniasis_Homo sapiens_hsa05140 | 1.21818409 |
| 41 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21229161 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.19462487 |
| 43 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.15295883 |
| 44 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.14739906 |
| 45 | * Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.12359792 |
| 46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.10722215 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.09394418 |
| 48 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.07644480 |
| 49 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.06900706 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.05449036 |
| 51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.04052295 |
| 52 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.03578331 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03459049 |
| 54 | RNA degradation_Homo sapiens_hsa03018 | 1.02717132 |
| 55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.02334549 |
| 56 | Thyroid cancer_Homo sapiens_hsa05216 | 1.01596519 |
| 57 | Asthma_Homo sapiens_hsa05310 | 0.99509140 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.98676059 |
| 59 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.96686017 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.95059226 |
| 61 | Carbon metabolism_Homo sapiens_hsa01200 | 0.90181507 |
| 62 | Galactose metabolism_Homo sapiens_hsa00052 | 0.87082511 |
| 63 | * Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.85873029 |
| 64 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.85721547 |
| 65 | Phototransduction_Homo sapiens_hsa04744 | 0.85619079 |
| 66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84246089 |
| 67 | Cell cycle_Homo sapiens_hsa04110 | 0.84207731 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.83844891 |
| 69 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.83388823 |
| 70 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.81334680 |
| 71 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.80484342 |
| 72 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.79912109 |
| 73 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.79653864 |
| 74 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.77937209 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.77501438 |
| 76 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74646450 |
| 77 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.72851293 |
| 78 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71866346 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70307723 |
| 80 | Influenza A_Homo sapiens_hsa05164 | 0.69726704 |
| 81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69547189 |
| 82 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.67242573 |
| 83 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.66981261 |
| 84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66249877 |
| 85 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.65813959 |
| 86 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65668867 |
| 87 | Legionellosis_Homo sapiens_hsa05134 | 0.65085923 |
| 88 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.64860373 |
| 89 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64467148 |
| 90 | RNA transport_Homo sapiens_hsa03013 | 0.64115188 |
| 91 | Malaria_Homo sapiens_hsa05144 | 0.62572443 |
| 92 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.60116643 |
| 93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57562016 |
| 94 | Parkinsons disease_Homo sapiens_hsa05012 | 0.57308016 |
| 95 | Bladder cancer_Homo sapiens_hsa05219 | 0.56103374 |
| 96 | Tuberculosis_Homo sapiens_hsa05152 | 0.54877209 |
| 97 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.53960815 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53741534 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | 0.52233629 |
| 100 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.52188109 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52121705 |
| 102 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.52118683 |
| 103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50778670 |
| 104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50053300 |
| 105 | Hepatitis B_Homo sapiens_hsa05161 | 0.49910089 |
| 106 | Huntingtons disease_Homo sapiens_hsa05016 | 0.48427579 |
| 107 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48158520 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47821469 |
| 109 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46945617 |
| 110 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46791835 |
| 111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46382706 |
| 112 | Lysosome_Homo sapiens_hsa04142 | 0.46150237 |
| 113 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.44670304 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44553107 |
| 115 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.42812616 |
| 116 | Viral myocarditis_Homo sapiens_hsa05416 | 0.42587680 |
| 117 | Shigellosis_Homo sapiens_hsa05131 | 0.41269577 |
| 118 | Salmonella infection_Homo sapiens_hsa05132 | 0.40401968 |
| 119 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40322115 |
| 120 | * Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40143057 |
| 121 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38940199 |
| 122 | Hepatitis C_Homo sapiens_hsa05160 | 0.38048610 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36957459 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36218178 |
| 125 | Circadian rhythm_Homo sapiens_hsa04710 | 0.35828132 |
| 126 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35468938 |
| 127 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35440186 |
| 128 | Alzheimers disease_Homo sapiens_hsa05010 | 0.33467151 |
| 129 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.33434611 |
| 130 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33415692 |
| 131 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.32805871 |
| 132 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.31861473 |
| 133 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.30362569 |
| 134 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.26755612 |
| 135 | Phagosome_Homo sapiens_hsa04145 | 0.26033105 |
| 136 | Alcoholism_Homo sapiens_hsa05034 | 0.25810900 |

